168 related articles for article (PubMed ID: 11961212)
1. PBPK modeling of the percutaneous absorption of perchloroethylene from a soil matrix in rats and humans.
Poet TS; Weitz KK; Gies RA; Edwards JA; Thrall KD; Corley RA; Tanojo H; Hui X; Maibach HI; Wester RC
Toxicol Sci; 2002 May; 67(1):17-31. PubMed ID: 11961212
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the percutaneous absorption of trichloroethylene in rats and humans using MS/MS real-time breath analysis and physiologically based pharmacokinetic modeling.
Poet TS; Corley RA; Thrall KD; Edwards JA; Tanojo H; Weitz KK; Hui X; Maibach HI; Wester RC
Toxicol Sci; 2000 Jul; 56(1):61-72. PubMed ID: 10869454
[TBL] [Abstract][Full Text] [Related]
3. Utility of real time breath analysis and physiologically based pharmacokinetic modeling to determine the percutaneous absorption of methyl chloroform in rats and humans.
Poet TS; Thrall KD; Corley RA; Hui X; Edwards JA; Weitz KK; Maibach HI; Wester RC
Toxicol Sci; 2000 Mar; 54(1):42-51. PubMed ID: 10746930
[TBL] [Abstract][Full Text] [Related]
4. Use of a physiologically based model to predict systemic uptake and respiratory elimination of perchloroethylene.
Dallas CE; Muralidhara S; Chen XM; Ramanathan R; Varkonyi P; Gallo JM; Bruckner JV
Toxicol Appl Pharmacol; 1994 Sep; 128(1):60-8. PubMed ID: 8079355
[TBL] [Abstract][Full Text] [Related]
5. Use of real-time breath analysis and physiologically based pharmacokinetic modeling to evaluate dermal absorption of aqueous toluene in human volunteers.
Thrall KD; Weitz KK; Woodstock AD
Toxicol Sci; 2002 Aug; 68(2):280-7. PubMed ID: 12151623
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the dermal absorption of aqueous toluene in F344 rats using real-time breath analysis and physiologically based pharmacokinetic modeling.
Thrall KD; Woodstock AD
J Toxicol Environ Health A; 2002 Dec; 65(24):2087-100. PubMed ID: 12515588
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the dermal bioavailability of aqueous xylene in F344 rats and human volunteers.
Thrall K; Woodstock A
J Toxicol Environ Health A; 2003 Jul; 66(13):1267-81. PubMed ID: 12851123
[TBL] [Abstract][Full Text] [Related]
8. A distributed parameter physiologically-based pharmacokinetic model for dermal and inhalation exposure to volatile organic compounds.
Roy A; Weisel CP; Lioy PJ; Georgopoulos PG
Risk Anal; 1996 Apr; 16(2):147-60. PubMed ID: 8638037
[TBL] [Abstract][Full Text] [Related]
9. A real-time in-vivo method for studying the percutaneous absorption of volatile chemicals.
Thrall KD; Poet TS; Corley RA; Tanojo H; Edwards JA; Weitz KK; Hui X; Maibach HI; Wester RC
Int J Occup Environ Health; 2000; 6(2):96-103. PubMed ID: 10828137
[TBL] [Abstract][Full Text] [Related]
10. The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene.
Covington TR; Robinan Gentry P; Van Landingham CB; Andersen ME; Kester JE; Clewell HJ
Regul Toxicol Pharmacol; 2007 Feb; 47(1):1-18. PubMed ID: 16901594
[TBL] [Abstract][Full Text] [Related]
11. Physiologically based pharmacokinetic model useful in prediction of the influence of species, dose, and exposure route on perchloroethylene pharmacokinetics.
Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
J Toxicol Environ Health; 1995 Mar; 44(3):301-17. PubMed ID: 7897693
[TBL] [Abstract][Full Text] [Related]
12. Assessing interaction thresholds for trichloroethylene in combination with tetrachloroethylene and 1,1,1-trichloroethane using gas uptake studies and PBPK modeling.
Dobrev ID; Andersen ME; Yang RS
Arch Toxicol; 2001 May; 75(3):134-44. PubMed ID: 11409535
[TBL] [Abstract][Full Text] [Related]
13. Bayesian analysis of a physiologically based pharmacokinetic model for perchloroethylene in humans.
Qiu J; Chien YC; Bruckner JV; Fisher JW
J Toxicol Environ Health A; 2010; 73(1):74-91. PubMed ID: 19953421
[TBL] [Abstract][Full Text] [Related]
14. Development of a physiologically based pharmacokinetic model for perchloroethylene using tissue concentration-time data.
Dallas CE; Chen XM; O'Barr K; Muralidhara S; Varkonyi P; Bruckner JV
Toxicol Appl Pharmacol; 1994 Sep; 128(1):50-9. PubMed ID: 8079354
[TBL] [Abstract][Full Text] [Related]
15. Computer simulation of the lactational transfer of tetrachloroethylene in rats using a physiologically based model.
Byczkowski JZ; Kinkead ER; Leahy HF; Randall GM; Fisher JW
Toxicol Appl Pharmacol; 1994 Apr; 125(2):228-36. PubMed ID: 8171430
[TBL] [Abstract][Full Text] [Related]
16. Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene.
Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
Environ Res; 1994 Oct; 67(1):54-67. PubMed ID: 7925194
[TBL] [Abstract][Full Text] [Related]
17. Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE).
Gearhart JM; Mahle DA; Greene RJ; Seckel CS; Flemming CD; Fisher JW; Clewell HJ
Toxicol Lett; 1993 May; 68(1-2):131-44. PubMed ID: 8516760
[TBL] [Abstract][Full Text] [Related]
18. PBTK modeling demonstrates contribution of dermal and inhalation exposure components to end-exhaled breath concentrations of naphthalene.
Kim D; Andersen ME; Chao YC; Egeghy PP; Rappaport SM; Nylander-French LA
Environ Health Perspect; 2007 Jun; 115(6):894-901. PubMed ID: 17589597
[TBL] [Abstract][Full Text] [Related]
19. Lactational transfer of tetrachloroethylene in rats.
Byczkowski JZ; Fisher JW
Risk Anal; 1994 Jun; 14(3):339-49. PubMed ID: 8029506
[TBL] [Abstract][Full Text] [Related]
20. Effect of PBPK model structure on interpretation of in vivo human aqueous dermal exposure trials.
Norman AM; Kissel JC; Shirai JH; Smith JA; Stumbaugh KL; Bunge AL
Toxicol Sci; 2008 Jul; 104(1):210-7. PubMed ID: 18381354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
